Position in FULC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,839,929
-$4,207,135 QoQ
Shares Held
1,049,161
0.0% QoQ
Ownership
1.38%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#23
of 154 holders
Holding Since
Dec 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Derivatives in FULC
reported options exposure · as of Jun 30, 2025CallValue
$3,673,920
CallShares
534,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. FULC ranks #46 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in FULC
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,839,929 | 1,049,161 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,047,064 | 1,049,161 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,556,588 | 1,375,472 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $11,860,870 | 1,289,225 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,673,920 | 534,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $2,948,224 | 428,521 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $576,276 | 200,096 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $940,451 | 200,096 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $81,396 | 22,800 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $267,750 | 75,000 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $1,509,396 | 422,800 | Call | Sole | 2024-11-14 | |
| 2022-06-30 | $892,780 | 182,200 | Call | Sole | 2022-08-12 | |
| 2021-06-30 | $1,705,096 | 162,700 | Shares | Sole | 2021-08-18 | |
| 2021-03-31 | $5,026,985 | 426,739 | Shares | Sole | 2021-08-18 | |
| 2020-12-31 | $5,125,467 | 437,700 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||